ABIOMED is a provider of temporary mechanical circulatory support devices and it provides a range of care to heart failure patients. Co. develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. Co.'s products include: the Impella 2.5 device, which is a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which primarily used by either interventional cardiologists; and Impella RP, a percutaneous catheter-based axial flow pump designed to allow more than four liters of flow per minute. We show 37 historical shares outstanding datapoints in our ABMD shares outstanding history coverage, used to compute ABMD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ABMD market cap history over the course of time is important for investors
interested in comparing ABMD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ABMD versus a peer is one thing; comparing
ABMD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ABMD can fluctuate over the course of history.
With this page we aim to empower investors researching ABMD by allowing them to research the ABMD market cap history. |
Video: The Importance of Market Cap
